Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus
Press Release April 11, 2018 New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus Today Enzymatica announced the results of an in vitro study demonstrating the ability of ColdZyme® Mouth Spray to deactivate human corona virus - one of the most common cold virus families. Along with the in vitro results from a study published in the autumn of 2017[1], ColdZyme has been shown to be able to deactivate over 90 % of the known viruses that cause colds. The current results, which are being presented today at Ear-Nose-and-Throat days in Linköping[2], show